Sabitlenmiş Tweet
Michael Burry Stock Tracker ♟
3.6K posts

Michael Burry Stock Tracker ♟
@burrytracker
Tracking hedge funds and Burry’s stocks. Powered by @joinautopilot
View my stock positions → Katılım Haziran 2022
143 Takip Edilen495.3K Takipçiler

@exec_sum This was extremely difficult to watch
English

@shaaaawty_7 Look into his other positions
English

@burrytracker Just crazy. I missed the boat on this one, definitely think it’s too late and there will be a correction at some point. But money glitch for sure for those that got in.
English

See full portfolio + performance + disclaimers here
marketplace.joinautopilot.com/landing/1/9535…
And yes, the performance is even with the delay
English

@unusual_whales gamestop has cash to spend… wow
20% above current price
English

@WhiteHouse idk if this should’ve been posted today
English

@KobeissiLetter Nice to see the other airlines coming together
English

BREAKING: The US government announces a relief plan for Spirit Airlines customers and the company's 17,000 employees.
Details include:
1. United, Delta, JetBlue, and Southwest are all capping ticket prices specifically for Spirit customers who now need to rebook cancelled flights
2. American Airlines and Delta Air Lines are offering reduced fares on high-volume Spirit routes
3. Allegiant has committed to freezing fare prices across routes that overlap with Spirit, and Frontier is offering up to 50% off base fares until May 10th
4. Most major US carriers are extending travel pass benefits and spare jump seats to Spirit pilots, flight attendants, and other employees who need to return home
5. Major US carriers also offer Spirit team members preferential employment interviews
Spirit Airlines officially shuts down after 33 years.
English
Michael Burry Stock Tracker ♟ retweetledi

Mfs think an AI come out perform insider trading

The Claude Portfolio@theaiportfolios
Milestone: The Claude Portfolio just passed $15,000,000 in capital on Autopilot. 'Capital' here refers to those who've connected their brokerages and allocated funds to follow Claude’s stock picks automatically. What started as a $50K experiment to test whether Claude’s agents could outperform the market has grown into a social-driven investing community. Appreciate everyone following along as it continues to evolve.
English
Michael Burry Stock Tracker ♟ retweetledi

Breaking: Claude just bought a new stock and it's already up 8%
Earlier this morning, Claude took our $50,000 and opened a brand new position in Ardelyx $ARDX
Here's it's reasoning on why:
"I initiated a new position in Ardelyx $ARDX at Friday's open, sized at 6.31% of the book.
The core business is a specialty pharma compounder with two commercial products and accelerating revenue. IBSRELA is the only NHE3 inhibitor approved for IBS-C. The mechanism is distinct from the GC-C pathway that Linzess and Trulance use: NHE3 inhibition works through intestinal permeability and TRPV1 signaling, which matters for the roughly 30 to 40% of IBS-C patients who do not tolerate GC-C drugs.
Q1 2026 revenue came in at $70.1M, up 58% year-over-year, with full-year guidance maintained at $410 to $430M. XPHOZAH, the renal drug for hyperphosphatemia, is adding paid prescriptions at +19% per quarter.
The asymmetric edge is the Zydus filing. On April 24, Zydus Lifesciences registered "Zara Merger Sub Inc." on the BSE: a 100% Zydus-owned Delaware entity capitalized at $1,000.
That is textbook M&A vehicle structure. Zydus has a Rs. 5,000 crore QIP approved by shareholders, with Jefferies, JPM, and IIFL Capital retained as advisors.
The implied acquisition range based on precedent specialty pharma takeouts is $2.2 to $2.5 billion, representing a 60 to 90% premium to the pre-announcement trading range. Jefferies raised its price target from $8 to $15 on April 27, the most aggressive recent sell-side move, which I read as the street beginning to price this signal.
The risk profile is why this position works inside the current portfolio context. Beta of 0.66 is the lowest among candidates with material expected return. The May binary cluster creates significant event-driven variance across the rest of the book.
ARDX has no binary in the 90-day window. The catalysts are idiosyncratic: revenue execution on the FY26 guide and the Zydus M&A process. Neither is correlated to the Iran/Hormuz macro scenario or the Warsh rate-path risk that dominates the other positions.
Expected: 1M +6.6% | 3M +22% | 12M +51.2%"
New updated full portfolio:
$NOW: 12.02%
$VST: 10.08%
$MSFT: 8.37%
$LLY: 7.98%
$CI: 7.11%
$ARDX: 6.79%
$ICE: 6.50%
$RDDT: 6.20%
$DVN: 5.78%
$HALO: 5.68%
$KTOS: 5.58%
$NVDA: 4.99%
$MA: 4.79%
$QXO: 4.17%
$AVGO: 3.96%

English

@unusual_whales Are we surprised anymore that the initial estimates from the government are always off by ~50%
English

See the full portfolio + performance + disclaimer of Buffett here:
marketplace.joinautopilot.com/landing/1/28825
And yes, the performance is even with the delay
English

@unusual_whales The glaze for Mythos is out of control
English

















